I now have comprehensive information from Harrison's 22E (2025), Bradley & Daroff's Neurology, and Rosen's Emergency Medicine. Let me compile the full answer.
Acute Meningitis: Initial Management
1. Immediate Assessment - Recognize the Syndrome
The classic triad is fever + headache + neck stiffness (nuchal rigidity). Additional features include photophobia, phonophobia, altered sensorium, and seizures. Meningococcal disease may present with a petechial/purpuric rash - this is an emergency.
"CNS infection should be considered in all patients with headache, nuchal rigidity, fever, altered sensorium, or diffuse or focal neurologic findings." - Rosen's Emergency Medicine
2. The Critical Time-Pressure Principle
Do NOT delay antibiotics for imaging or LP. Every hour of delay in antibiotic administration increases mortality.
The recommended sequence depends on clinical status:
| Clinical Scenario | Action Sequence |
|---|
| No focal deficits, normal consciousness, no papilledema | Blood cultures → LP → Antibiotics + Dexamethasone |
| Focal deficits, altered consciousness, papilledema, or immunocompromised | Blood cultures → Antibiotics + Dexamethasone immediately → CT → LP |
| Critically ill / septic shock | Blood cultures → Antibiotics + Dexamethasone (do NOT wait for anything) |
3. Step-by-Step Initial Management
Step 1 - Blood Cultures
Draw 2 sets of blood cultures before any antibiotics. These take only ~2 minutes and help identify the organism even if CSF cultures are later sterilized.
Step 2 - Dexamethasone (Before or With First Antibiotic Dose)
- Dose: 0.15 mg/kg IV q6h x 4 days (max 10 mg q6h)
- Timing: Ideally 20 minutes before, or at least concurrent with, the first antibiotic dose
- Proven to reduce mortality and hearing loss in pneumococcal meningitis (landmark 2002 de Gans RCT)
- Do not start dexamethasone after antibiotics have already been given - no proven benefit
"Therapy with dexamethasone should ideally be started 20 min before, or not later than concurrent with, the first dose of antibiotics." - Harrison's Principles of Internal Medicine 22E (2025)
Step 3 - Empirical Antibiotics
Choose based on age and risk factors:
| Patient Group | Likely Organisms | Empirical Regimen |
|---|
| Neonates (< 1 month) | Group B Strep, E. coli, Listeria, Klebsiella | Ampicillin + Cefotaxime (or Gentamicin) |
| Infants (1-3 months) | Group B Strep, S. pneumoniae, Listeria, H. influenzae | Ampicillin + Ceftriaxone |
| Children & Adults (3 mo - 50 yr) | S. pneumoniae, N. meningitidis | Ceftriaxone (2g IV q12h) + Vancomycin |
| Adults > 50 yr or immunocompromised | As above + Listeria | Ceftriaxone + Vancomycin + Ampicillin (2g IV q4h) |
| Post-neurosurgery / CSF shunt | S. aureus, coag-neg Staph, Pseudomonas | Vancomycin + Cefepime (or Meropenem) |
Why vancomycin? Due to increasing penicillin-resistant S. pneumoniae globally, ceftriaxone alone is insufficient. Dexamethasone does NOT meaningfully reduce CSF vancomycin levels (Ricard 2007 study confirmed adequate CSF penetration).
"First-line treatment for healthy adults with suspected bacterial meningitis is ceftriaxone or cefotaxime plus vancomycin in most countries given high antibiotic resistance." - Rosen's Emergency Medicine
Step 4 - Lumbar Puncture (When Safe)
Perform LP for CSF analysis. LP is safe without prior CT if:
- Normal level of consciousness
- No focal neurologic deficits
- No papilledema
- No recent head trauma
- Immunocompetent
Classic CSF findings in bacterial meningitis:
| Parameter | Finding |
|---|
| Opening pressure | Elevated (>180 mmH2O in 90%) |
| WBC | PMN pleocytosis, >100 cells/μL in 90% |
| Glucose | <40 mg/dL, CSF/serum ratio <0.4 |
| Protein | >45 mg/dL in 90% |
| Gram stain | Positive in >60% |
| Culture | Positive in >70% |
Also send: Gram stain, C&S, glucose, protein, cell count, lactate, FilmArray PCR panel (if available - detects S. pneumoniae, N. meningitidis, HSV, and other pathogens rapidly).
Step 5 - Additional Measures
- IV access + fluid resuscitation if signs of sepsis
- Airway management if GCS ≤8 or rapidly deteriorating
- Seizure management - benzodiazepines acutely; consider prophylactic levetiracetam in high-risk patients
- ICP management if signs of raised ICP: head of bed 30°, avoid hypotonic fluids, consider mannitol 0.25-0.5 g/kg; intubation + controlled ventilation if herniation imminent
- Aciclovir 10 mg/kg IV q8h - add empirically if HSV encephalitis is possible (altered behaviour, temporal lobe features) or when viral vs bacterial distinction is uncertain
- Isolation precautions for suspected N. meningitidis (droplet) until 24h of effective antibiotics
- Chemoprophylaxis for close contacts of N. meningitidis: Rifampin 600 mg PO q12h x 2 days, or single-dose Ciprofloxacin 500 mg PO, or Ceftriaxone 250 mg IM
4. Monitoring and Reassessment
- Repeat LP at 36-48h if no clinical improvement to confirm CSF sterilization
- Narrow antibiotics once culture and sensitivity results are available
- Dexamethasone may be discontinued if the pathogen is NOT S. pneumoniae (less clear benefit for other organisms)
- Monitor for complications: SIADH (fluid restrict if serum Na falls), hearing loss, hydrocephalus, subdural empyema
Summary Flow
Suspect meningitis (fever + headache + neck stiffness ± rash ± altered consciousness)
↓
Blood cultures × 2 immediately
↓
Focal deficits/papilledema/altered consciousness?
YES → Dexamethasone + Antibiotics NOW → CT → LP
NO → LP first (safe) → Dexamethasone + Antibiotics
↓
Adults: Ceftriaxone 2g IV q12h + Vancomycin 15-20mg/kg IV q8-12h ± Ampicillin (if >50yr)
+ Dexamethasone 0.15mg/kg IV q6h x 4 days (before/with first antibiotic dose)
↓
Supportive care: fluids, airway, ICP management, seizure control
+ Add Aciclovir if HSV encephalitis cannot be excluded
Sources: Harrison's Principles of Internal Medicine 22E (2025), p. 1163-1164 | Bradley and Daroff's Neurology in Clinical Practice, p. 1214-1217 | Rosen's Emergency Medicine, p. 2268